var quiz = [
    {
        q: `Advantages of using mpMRI to identify suitable candidates for prostate focal therapy include all the following EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->It improves the detection of anterior zone cancers`,
         `<!--b. -->It preferentially detects high-grade lesions`, 
         `<!--c. -->It accurately estimates lesion size for determination of ablation margin`, 
         `<!--d. -->It improves the detection of extra-prostatic extension`, 
         `<!--e. -->It helps accurately identify the index lesion` ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: mpMRI has been consistently shown to underestimate the actual tumor volume by 5% to 30% in historadiological correlation studies.`,
        state: `notAnswered`,
        userAnswered: []
    ,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},{
        q: `Selection of an ablative energy source for prostate focal therapy is predicated on:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->availability of ablative technology.`,
         `<!--b. -->lesion location.`, 
         `<!--c. -->presence of extensive intra-prostatic calcifications.`, 
         `<!--d. -->both (a) and (b).`, 
         `<!--e. -->all of the above.` ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: The oncological premise of focal therapy is to completely destroy the index lesion while preserving as much function as possible. As such, selection of the ablative technology will depend on availability, operator experience, desired approach, and the suitability of the technology to deliver a lethal dose of energy to the desired location in order to successfully ablate the lesion.`,
        state: `notAnswered`,
        userAnswered: []
    ,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},{
        q: `Technical innovations improving focal cryotherapy for prostate cancer include all EXCEPT the use of:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->transrectal ultrasound.`,
         `<!--b. -->urethral warming catheters.`, 
         `<!--c. -->warming of neurovascular bundles.`, 
         `<!--d. -->thermocouples placed in critical areas of the prostate.`, 
         `<!--e. -->smaller-diameter cryoprobes allowing percutaneous insertion.` ],
        optionStyleType: `st-lower-alpha`,
        answer: [2],
        ansText: `Rationale: Use of transrectal ultrasonography (TRUS) for real-time monitoring of the freezing process, use of a urethral warming catheter, use of thermocouples placed in critical areas of the prostate, and improved cryoprobes allowing percutaneous insertion are technical innovations that have all contributed to improving cryotherapy for prostate cancer.`,
        state: `notAnswered`,
        userAnswered: []
            ,
        type: `MCSS`},{
        q: `What is the most clinically important parameter of tissue ablation other than lowest temperature achieved by cryotherapy?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->The diameter of the cryoprobe`,
         `<!--b. -->The number of freeze/thaw cycles`, 
         `<!--c. -->The velocity of tissue thawing`, 
         `<!--d. -->The velocity of tissue freezing`, 
         `<!--e. -->The duration of freezing` ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: In a clinical setting, the number of freezing cycles, the lowest temperature achieved, and the existence of any regional “heat sinks” may be more important factors relating to cancer destruction. Repeating a freeze/thaw cycle results in more extensive tissue damage compared with a single cycle.`,
        state: `notAnswered`,
        userAnswered: []
    ,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},{
        q: `What is the characteristic appearance of ice ball created during prostate focal cryotherapy on ultrasound?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Mixed echogenicity`,
         `<!--b. -->Hyperechogenicity`, 
         `<!--c. -->Anechogenicity with a hypochogenic rim`, 
         `<!--d. -->Hypoechogenicity with a hyperechogenic rim`, 
         `<!--e. -->None of the above` ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: Frozen tissue is significantly different from unfrozen tissue in sound impedance, resulting in strong echo reflection at the interface of frozen and normal tissue. The frozen area can be seen as a well-marginated hyperechoic rim with acoustic shadowing by ultrasonography. Sonography provides no information about the temperature distribution within the ice, nor does it show the extent of freezing at the lateral or anterior aspects of the prostate.`,
        state: `notAnswered`,
        userAnswered: []
    ,
	type: `MCSS`,
	type: `MCSS`,
	type: `MCSS`        ,
        type: `MCSS`},{
        q: `Prostate cell death is likely to occur completely in a single freeze cycle when tissue temperature reaches:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->20°C.`,
         `<!--b. -->0°C.`, 
         `<!--c. -->−20°C.`, 
         `<!--d. -->−40°C.`, 
         `<!--e. -->none of the above.` ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: Complete cell death is unlikely to occur at temperatures higher than −20°C, and temperatures lower than −40° C are required to completely destroy cells.`,
        state: `notAnswered`,
        userAnswered: []
            ,
        type: `MCSS`},{
        q: `High-intensity focused ultrasound (HIFU) exerts what effect on prostate tissue?`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->Tissue fragmentation with disruption of vascular architecture`,
         `<!--b. -->Coagulative necrosis`, 
         `<!--c. -->Nuclear injury`, 
         `<!--d. -->Cavitation`, 
         `<!--e. -->Disruption of protein synthesis` ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: Highly focused sound energy results in mechanical and thermal effects on tissue. In the case of HIFU, the primary mechanism of tissue ablation is by raising the temperature in the tissue above the level needed to create coagulative necrosis.`,
        state: `notAnswered`,
        userAnswered: []
            ,
        type: `MCSS`},{
        q: `There exists level 1 evidence that prostate focal therapy:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->is equivalent to radical therapy in terms of cancer control.`,
         `<!--b. -->is superior to active surveillance for progression free survival.`, 
         `<!--c. -->is superior to active surveillance for overall survival.`, 
         `<!--d. -->is equivalent to active surveillance for overall survival.`, 
         `<!--e. -->is superior to radical therapy in terms of sexual function outcomes.` ],
        optionStyleType: `st-lower-alpha`,
        answer: [1],
        ansText: `Rationale: Azzouzi et al. randomized 415 men with low-risk prostate cancer to focal VTP or active surveillance demonstrating that FT significantly improved negative biopsy at 2 years and decreased disease progression and those requiring definitive disease intervention. Of the 216 men assigned to VTP, 196 received the treatment and 195 completed 24 months of follow-up. In the AS arm, 174 men completed 24 months of follow-up. Overall, cancer progression rate (volume, grade, or PSA progression) in the AS arm was 58% compared to 28% in the VTP arm. This is the first randomized trial with level 1 evidence comparing focal therapy to an accepted management strategy demonstrating a meaningful clinical benefit.`,
        state: `notAnswered`,
        userAnswered: []
            ,
        type: `MCSS`},{
        q: `The following modalities all employ a thermal form of ablation EXCEPT:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->MRI-guided transurethral ultrasound ablation.`,
         `<!--b. -->focal laser ablation.`, 
         `<!--c. -->focal cryotherapy.`, 
         `<!--d. -->vascular-targeted photodynamic therapy.`, 
         `<!--e. -->none of the above.` ],
        optionStyleType: `st-lower-alpha`,
        answer: [3],
        ansText: `Rationale: In VTP, low-power near-infrared laser light of specific wavelength destroys targeted tissues that have been photosensitized with an intravascular agent preferentially taken up by tumor cells. This occurs via the production of reactive oxygen species in the target zone causing irreversible damage to cell membranes and small arterioles leading to tumor necrosis.`,
        state: `notAnswered`,
        userAnswered: []
            ,
        type: `MCSS`},{
        q: `Reliable markers of post-focal therapy treatment success include:`,
        q2: ``,
        q3: [],
        option: [`<!--a. -->post-treatment PSA levels.`,
         `<!--b. -->digital rectal examination.`, 
         `<!--c. -->post-treatment mpMRI alone.`, 
         `<!--d. -->targeted biopsy of the treated area only.`, 
         `<!--e. -->targeted biopsy of the treated area plus a systematic biopsy.` ],
        optionStyleType: `st-lower-alpha`,
        answer: [4],
        ansText: `Rationale: A 2015 ICUD consensus on follow-up after focal therapy recommended an mpMRI with mandatory targeted biopsy of 4 to 6 cores in the treated area at 3 to 6 months, then mpMRI at 1 to 2 and 5 years with targeted biopsy as needed, especially if a new lesion should become manifest. A systematic biopsy was also recommended at 1 to 2 and 5 years to provide further histological evaluation of the untreated zone for potential outfield recurrence.`,
        state: `notAnswered`,
        userAnswered: []
            ,
        type: `MCSS`}
]